Which of the following medications—sodium chloride 0.9% infusion 50 mL/hr three times daily, sulfamethoxazole‑trimethoprim 800/160 mg daily, duloxetine 60 mg every 12 hours, oxycodone 5 mg as needed, levofloxacin 250 mg daily, lisinopril 5 mg daily, midodrine 10 mg three times daily, bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy) daily, metoprolol succinate extended‑release 25 mg daily, acetaminophen 325 mg two tablets as needed, pregabalin 100 mg twice daily, topiramate 50 mg twice daily, fluticasone‑salmeterol inhalation, tiotropium inhalation, nystatin‑triamcinolone cream, nystatin powder, levothyroxine 100 µg daily, atorvastatin 80 mg at bedtime, bisacodyl suppository 10 mg as needed, fleet enema as needed, pantoprazole 40 mg twice daily, ipratropium‑albuterol solution as needed, sumatriptan 50 mg as needed, and albuterol‑budesonide inhaler as needed—have the potential to affect kidney function?

Medications That Can Affect Kidney Function

Yes, several medications on this list can significantly affect kidney function, with the highest-risk agents being sulfamethoxazole-trimethoprim, levofloxacin, Biktarvy (tenofovir alafenamide), and lisinopril—requiring close monitoring of renal function, especially when used in combination.

High-Risk Nephrotoxic Medications

Sulfamethoxazole-Trimethoprim (Bactrim) 800-160 mg daily

This antibiotic affects kidney function through multiple mechanisms 1:

• Direct tubular effects: Trimethoprim blocks epithelial sodium channels in the distal nephron, causing functional kidney changes
• Hyperkalemia risk: Particularly dangerous when combined with lisinopril (ACE inhibitor), creating a high-risk drug interaction 2
• Dose adjustment required: When creatinine clearance <30 mL/min, dosing intervals must be extended 3, 4
• Accumulation of metabolites: N-acetyl sulfamethoxazole accumulates significantly in renal insufficiency 5

Critical warning: The combination of sulfamethoxazole-trimethoprim + lisinopril + potential volume depletion creates substantial hyperkalemia risk 2. Monitor potassium closely.

Levofloxacin 250 mg daily

Fluoroquinolones cause both functional and structural kidney injury 6:

• Direct tubular toxicity: Can cause acute tubular necrosis
• Crystal nephropathy: Particularly with inadequate hydration
• CNS effects amplified in renal dysfunction: Dose reduction required when creatinine clearance is reduced 2

Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide)

The tenofovir component affects kidney function 6:

• Proximal tubular dysfunction: Can cause Fanconi syndrome
• Reduced GFR: Causes functional decline in glomerular filtration
• Requires monitoring: Baseline and periodic renal function assessment mandatory
• Less nephrotoxic than TDF: Tenofovir alafenamide (TAF) is safer than the older tenofovir disoproxil fumarate formulation

Lisinopril 5 mg daily

ACE inhibitors alter renal hemodynamics 6:

• Efferent arteriole dilation: Decreases intraglomerular pressure, causing functional GFR decline
• Paradoxically renoprotective: Despite causing creatinine rise, ACE inhibitors improve long-term kidney outcomes 6
• "Triple whammy" risk: When combined with diuretics and NSAIDs, dramatically increases AKI risk 6
• Do not discontinue for mild creatinine rise: A 30% increase in creatinine is expected and acceptable 6

Moderate-Risk Medications

Pregabalin 100 mg twice daily

• Renally eliminated: Requires dose adjustment in renal insufficiency
• Accumulation risk: Can cause toxicity if not dose-adjusted
• Not directly nephrotoxic: Does not cause kidney injury but accumulates

Topiramate 50 mg twice daily

• Metabolic acidosis: Can worsen kidney function indirectly
• Kidney stone risk: Increases calcium phosphate stone formation
• Renally eliminated: Dose adjustment needed in severe renal impairment

Atorvastatin 80 mg at bedtime

• Rare rhabdomyolysis: Can cause acute kidney injury through myoglobin-induced tubular damage
• Generally safe: Minimal direct renal effects at therapeutic doses

Medications Requiring Monitoring But Lower Direct Risk

Duloxetine, oxycodone, metoprolol, acetaminophen, pantoprazole, levothyroxine: These require dose adjustments in severe renal failure but are not primary nephrotoxins.

Inhaled medications (fluticasone-salmeterol, tiotropium, albuterol-budesonide, ipratropium-albuterol): Minimal systemic absorption, negligible renal effects.

Topical agents (nystatin-triamcinolone, nystatin powder): No significant renal impact.

Critical Drug Combinations to Monitor

The KDIGO 2020 guidelines emphasize that drug burden matters 6:

• This patient is receiving ≥3 nephrotoxic drugs simultaneously (sulfamethoxazole-trimethoprim, levofloxacin, Biktarvy, lisinopril)
• Risk multiplies exponentially: Studies show dramatically increased AKI risk with 3+ nephrotoxic agents 6

Specific High-Risk Combination Present:

Sulfamethoxazole-trimethoprim + Lisinopril = Severe hyperkalemia risk 2

• Monitor potassium at baseline, 1 week, and monthly
• Consider holding one agent if potassium >5.0 mmol/L
• This combination specifically flagged in 2019 AGS Beers Criteria 2

Monitoring Algorithm

For this patient, implement the following:

1. Baseline assessment:

   • Serum creatinine, eGFR, potassium, sodium
   • Urinalysis for proteinuria

2. During treatment:

   • Recheck creatinine/eGFR weekly while on antibiotics (sulfamethoxazole-trimethoprim, levofloxacin)
   • Potassium monitoring: 3-7 days after starting sulfamethoxazole-trimethoprim, then weekly 1
   • Sodium monitoring: High-dose sulfamethoxazole-trimethoprim causes hyponatremia in 72% of patients 7

3. Long-term monitoring:

   • Biktarvy: Renal function every 3-6 months
   • Lisinopril: Acceptable creatinine rise up to 30% from baseline 6

Common Pitfalls to Avoid

• Do not discontinue lisinopril for mild creatinine elevation: This is expected and renoprotective long-term 6
• Do not ignore the "triple whammy": If NSAIDs are added to lisinopril, AKI risk skyrockets 6
• Do not continue antibiotics without monitoring: Both sulfamethoxazole-trimethoprim and levofloxacin require dose adjustment in renal impairment 1, 4
• Do not overlook hyperkalemia: The sulfamethoxazole-trimethoprim + lisinopril combination is particularly dangerous 2, 1

Sodium Chloride 0.9% Infusion

The 50 mL/hr three times daily regimen is protective against nephrotoxicity 6:

• Adequate hydration prevents drug crystallization
• Maintains renal perfusion pressure
• Mitigates hemodynamic effects of ACE inhibitors

However, monitor for fluid overload, which can paradoxically worsen kidney function through venous congestion 6.